Andera Partners
- SEC CIK
- 0001757283
- Latest filing
- Jul 22, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Jul 22, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 8
- +1 vs. Q1 2026
- Portfolio value
- $206.5M
- +$29.6M (+16.7%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NYXHNyxoah SA | COMMONSTOCK | 522,057 | $882.3K | 0.4% | 00.0% | Unchanged | History |
| ABVXAbivax S.A. | SPONSORED ADS | 78,125 | $10.4M | 5.0% | 00.0% | Unchanged | History |
| IVAInventiva S.A. | ADS | 3,633,181 | $13.7M | 6.7% | +1,815,000+99.8% | Added | History |
| EVMNEvommune, Inc. | COM SHS | 1,391,990 | $18.5M | 9.0% | −505,372−26.6% | Reduced | History |
| AGMBAgomAb Therapeutics NV | SPONSORED ADS | 1,538,702 | $20.0M | 9.7% | 00.0% | Unchanged | History |
| AVLNAvalyn Pharma Inc. | COM SHS | 929,824 | $30.6M | 14.8% | +929,824 | New | History |
| MLYSMineralys Therapeutics, Inc. | COM | 1,591,917 | $42.9M | 20.8% | 00.0% | Unchanged | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 2,728,679 | $69.4M | 33.6% | +33,487+1.2% | Added | History |